No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Shares in Fevertree Drinks fizzed higher on Tuesday after Jefferies upgraded the stock to 'buy' from 'hold' and hiked the price target to 1,100p from 900p, highlighting a "more refreshing growth story".
Jefferies said the deal with Molson Coors will provide a major uplift in scale and execution capability in the US, and de-risks the supply chain.
"Marketing spend is set to double, which will boost brand awareness," the bank said.
"The superior growth and margin profile of Fever's portfolio versus mainstream beer is a strong incentive for TAP and its distributors to push the brand.
"These levers position Fever for accelerating growth, margin recovery and higher cash returns."
Jefferies said that over and above the 8.5% shareholding in Fevertree, it sees Molson Coors fully aligned to grow the company's portfolio.
"The core beer portfolio in the US is under pressure and TAP's Acceleration Plan (Oct'23) is focused on: (a) aggressively premiumising its portfolio; and (b) scaling / expanding beyond beer," it said.
"Fever ticks the boxes on both of these initiatives," it said, adding that success with Fevertree in the US could add more than 200 basis points to Molson Coors' US growth over three years.
At 1305 BST, the shares were up 4.7% at 824.00p.
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.